Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Fragments of hyaluronan released after injury bind and activate TLR4 in a complex with CD44. Here we investigated if the recognition of hyaluronan by CD44 and TLR4 alters lipopolysaccaride (LPS) responsiveness and thus could alter the septic response. In contrast to mice injected with LPS, mice exposed to hyaluronan prior to LPS had greatly decreased serum IL-6 and TNFα and were protected from symptoms of sepsis. The protective effect of HA was not seen in Cd44−/− mice. Consistent with our findings in vivo, addition of hyaluronan to macrophages before LPS exposure significantly decreased the release of IL-6 and TNFα and this effect was not seen in macrophages from Cd44−/− mice. Investigation of the mechanism responsible for inhibition of LPS activation showed hyaluronan treatment resulted in an increase in peritoneal macrophage A20 mRNA expression, and that this was significantly reduced in macrophages from Cd44−/− mice and Tlr4 −/− mice. Suppression of the A20 response with siRNA inhibited the ability of hyaluronan to protect against the cytokine response to LPS. Therefore, our results show that hyaluronan acts through TLR4, CD44 and A20 to stimulate a unique cellular response that can protect against the septic response to LPS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Negative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509 · cited 1×
“Progress has been made in understanding mechanisms involved in the negative regulation of TLR signaling (Liew et al., 2005), an essential event through which the host attenuates TLR signaling to avoid detrimental effects of an excess inflammatory response.”
BackgroundFailure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice
Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P., & Ma, A. (2000) · Science · doi:10.1126/science.289.5488.2350 · Cited by 1,409 · cited 2×
“A20-deficient mice develop severe inflammation and cachexia, are hypersensitive to both LPS and TNF, and die due to the failure to regulate TNF-induced NF-κB activation (Boone et al., 2004; Lee et al., 2000).”
BackgroundRegulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401
Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378 · cited 2×
“Recent observations have shown that fragments of hyaluronan (HA) can serve as an endogenous trigger of TLR signaling and are able to activate innate immune defense, promoting the production of cytokines by a variety of cell types (Jiang et al., 2005; Termeer et al., 2002).”
BackgroundInnate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Self-citationHyaluronan Fragments Stimulate Endothelial Recognition of Injury through TLR4
Taylor, K. R., Trowbridge, J. M., Rudisill, J. A., Termeer, C. C., Simon, J. C., & Gallo, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310859200 · Cited by 545 · cited 4×
“HA was prepared by the method previously described (Taylor et al., 2004).”
BackgroundMethodSelf-citationA20 Blocks Endothelial Cell Activation through a NF-κB-dependent Mechanism
Cooper, J. T., Stroka, D. M., Brostjan, C., Palmetshofer, A., Bach, F. H., & Ferran, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18068 · Cited by 247 · cited 1×
“Furthermore, the ability of heterologous A20 expression to inhibit LPS-induced NFκB activity suggests that endogenous A20 may be important for the termination of LPS signals (Cooper et al., 1996).”
Background
Cited by
Hyaluronan as an Immune Regulator in Human Diseases
Jiang, D., Liang, J., & Noble, P. W. (2011) · Physiological Reviews · doi:10.1152/physrev.00052.2009 · Cited by 1,060
Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling
Płóciennikowska, A., Hromada-Judycka, A., Borzęcka, K., & Kwiatkowska, K. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1762-5 · Cited by 761
Hyaluronan: Biosynthesis and signaling
Vigetti, D., Karousou, E., Viola, M., Deleonibus, S., De Luca, G., & Passi, A. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.02.001 · Cited by 318
Hyaluronan in wound healing: Rediscovering a major player
Aya, K. L., & Stern, R. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12214 · Cited by 317
Varki, A. (2011) · Glycobiology · doi:10.1093/glycob/cwr087 · Cited by 263
“Thus, in contrast to an uncontrolled pro-inflammatory response to LPS, HA, by the engagement of CD44, results in down-regulation of immune reactivity (Teder et al. 2002; Muto et al. 2009; Jiang et al. 2011).”
Background
Metadata
- Authors
- Muto, J., Yamasaki, K., Taylor, K. R., & Gallo, R. L.
- Venue
- Molecular Immunology
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 47
- Issue
- 2-3
- Pages
- 449-456
- ISSN
- 0161-5890 (ISSN-L)
- OpenAlex
- W1973769178
- Cited by
- 123
- References
- 7
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.